Japan Drafts New Program to Enlarge its Orphan Drug Designation Program
On July 10, the Japanese MHLW outlined a plan to increase the number of products allowed to apply for Orphan Drug Designation (ODD) and permit this designation earlier in the drug development process. Currently, Japan only accepts orphan drugs that are for... Read More